NASDAQ | ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 9.23% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.94% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 6.62% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 5.56% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.08% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.88% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 3.71% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 3.49% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 3.05% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.76% |
| ROP | Roche Holding AG | 2.71% | ||
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.54% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.46% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.40% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.35% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.35% |
| MCK | McKesson Corporation | Healthcare | Medical Distribution | 2.26% |
| 0QIU | Novo Nordisk A/S Class B | 2.23% | ||
| UCB | UCB SA | Healthcare | Biotechnology | 2.14% |
| ARGX | Argen-X | Healthcare | Biotechnology | 2.06% |